Replies to post #90193 on Biotech Values

[DewDiligence]

VRTX:

A question on the call just asked about dosing 950 for more then 12 weeks (with 222) and they implied its not going to happen.

That was a good question—glad someone asked it. Telaprevir gets rid of wild-type virus really fast, so extending the duration of Telaprevir beyond 12 weeks does more harm than good. The question is what the VX-222-based regimen will consist of after 12 weeks, and the answer is evidently not yet known.